LACOG and the GOG Foundation partnership on the treatment of Gynecological Cancer

The Gynecologic Oncology Group (GOG) Foundation is an organization based in Columbia, in the United States, which works to promote clinical research in prevention and treatment of gynecologic cancers, such as ovarian, cervical , endometrial, vulvar, and vaginal cancers. The foundation has a network of over 400 members and has already given support on the conduction of 350 clinical trials, reaching over 115,000 patients. 

Institutions and investigators that belong to the GOG Foundation network are extremely important for the development of treatments and surgical procedures, for the quality of life analyses and prevention knowledge. The institution has support from industry and the National Cancer Institute (NCI) to conduct trials and generate results that are shared with participating members, health professionals, patients, and their families. The GOG Foundation is focused on the advances in Oncology to benefit cancer patients. 

LACOG has been working in partnership with the GOG Foundation, joining forces to support clinical studies. The aim of this partnership is to extend international cooperation to provide LACOG investigators the opportunity to participate in studies conducted worldwide. 

Likewise, this partnership allows LACOG to expand its portfolio of clinical trials, which extends the opportunity for Latin-American patients to participate in clinical research with the most advanced gynecological cancer treatments.